Company profile: CB Fleet
1.1 - Company Overview
Company description
- Provider of feminine care products for personal hygiene and comfort and over-the-counter (OTC) healthcare products addressing common health concerns, serving as a manufacturer, marketer, and distributor.
Products and services
- OTC Healthcare Products: Produces OTC healthcare products for various health and wellness needs across global-scale markets, OTC-classified
- Over-the-Counter Healthcare Products: Delivers OTC healthcare products aimed at addressing common health concerns, backed by Europe-scale subsidiaries in the UK, Spain, and Italy
- Feminine Care Products: Engineers a range designed for personal hygiene and comfort across international-scale markets
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to CB Fleet
Glycotope
HQ: Germany
Website
- Description: Provider of GMP-compliant contract manufacturing for active biopharmaceutical ingredients (proteins and antibodies) via recombinant production, and oncology antibody solutions including GT-001 (Lewis Y), GT-002 (LYPD3), GT-00A (MUC1) and an IL-15 immuno-cytokine, plus GlycoTarget Discovery and a platform enabling high tumor-specificity by targeting tumor-associated carbohydrates for ADC/CAR development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Glycotope company profile →
NPS Pharmaceuticals
HQ: United States
Website
- Description: Provider of therapies for rare diseases, dedicated to making a difference in the lives of patients who often have few, if any, treatment options.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NPS Pharmaceuticals company profile →
CorMedix
HQ: United States
Website
- Description: Provider of specialty pharmaceutical products targeting cardiac, renal, and infectious diseases. Offers DefenCath, a catheter lock solution with taurolidine and heparin to reduce catheter-related bloodstream infections in adult patients with kidney failure on chronic hemodialysis via central venous catheter.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CorMedix company profile →
Santarus
HQ: United States
Website
- Description: Provider of specialty biopharmaceutical products focused on acquiring, developing and commercializing proprietary therapies that address the needs of patients treated by physician specialists; current commercial efforts encompass five products, including UCERIS (budesonide) extended release tablets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Santarus company profile →
Dyax
HQ: United States
Website
- Description: Provider of biotherapeutics focused on the discovery, development and commercialization for unmet medical needs, with an emphasis on inflammatory and oncology indications; lead product DX-88 approved under the brand name KALBITOR (ecallantide) by the United States Food and Drug.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dyax company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for CB Fleet
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to CB Fleet
2.2 - Growth funds investing in similar companies to CB Fleet
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for CB Fleet
4.2 - Public trading comparable groups for CB Fleet
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →